2) clinical trial phase II design
Ⅱ期临床试验方案
1.
Comparison of 3 kinds of the clinical trial phase II design of niacin/lovastatine compound extended rellease tablet;
烟酸/洛伐他汀复方缓释片及其3种Ⅱ期临床试验方案的比较
4) phase Ⅱ clinical trial
Ⅱ期临床
1.
Objective: A prospective multicentre phase Ⅱ clinical trial of 125Ser-rhIL-2 was conducted to evaluate the response rate and adverse reaction in patients with malignant pleural/ peritoneal effusion and advanced solid tumor.
目的:通过前瞻性多中心Ⅱ期临床试验,观察重组人白细胞介素-2(125Ser-rhIL-2)对晚期实体肿瘤及恶性胸腹腔积液患者的疗效及不良反应。
6) phase Ⅲ clinical trial
Ⅲ期临床试验
1.
Methods: The phase Ⅲ clinical trial was conducted in 510 patients with chronic bronchitis.
方法:本试验为Ⅲ期临床试验,随机选取510例慢性支气管炎迁延期的患者,从咳嗽、咳痰、喘息、肺部哮鸣音、肺功能、肺部X线征象等方面观察治疗前后的变化,进行统计学处理,并考察其安全性。
补充资料：与期
1.预先期待。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条